Skip to main content
Clinical Trials/NCT03648034
NCT03648034
Completed
Not Applicable

Effects of Preoperative Scalp Nerve Block on Postoperative Recovery Quality in Patients Undergoing Excision of Intracranial Meningioma

RenJi Hospital1 site in 1 country144 target enrollmentSeptember 18, 2018
ConditionsMeningioma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Meningioma
Sponsor
RenJi Hospital
Enrollment
144
Locations
1
Primary Endpoint
KPS score
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Patients undergoing elective meningeoma resection surgery will be randomly assigned to one of the following two groups. After anesthesia induction but before skull-pin insertion, one group will receive scalp nerve blocks with 0.5% ropivacaine, whereas the other group will receive scalp nerve blocks with 0.9% saline. The patients' postoperative recovery quality, which is evaluated by KPS score, peri-operative inflammatory responses, and post-operative pain degree will be evaluated and compared between the two groups.

Detailed Description

Patients undergoing elective meningeoma resection surgery will be randomly assigned to one of the following two groups. After anesthesia induction but before skull-pin insertion, one group will receive scalp nerve blocks with 0.5% ropivacaine, whereas the other group will receive scalp nerve blocks with 0.9% saline. The patients' KPS scores at 3d after surgery and at discharge, serum levels of TNF-α、IL-6,IL-1β at 24h after surgery, satisfaction score after recovery, and VAS scores at 1, 2, 3 days post-surgery will be evaluated and compared between the two groups.

Registry
clinicaltrials.gov
Start Date
September 18, 2018
End Date
November 30, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jie Tian

Principal Investigator

RenJi Hospital

Eligibility Criteria

Inclusion Criteria

  • 18-75 years old;
  • BMI 18-28 kg/m2;
  • ASA Physical Status 1-2;
  • Clinical diagnosis of primary Meningeoma and will have elective Meningeoma Resection Surgery;
  • With an estimated surgery time of less than 4h;
  • The incision will be conducted at the frontal, top or the temperal skull.

Exclusion Criteria

  • A history of previous brain surgery;
  • Severe systemic disease (heart, lung, kidney, or immune system);
  • Nerval or mental disorders;
  • A history of addiction to opioids;
  • Allergic to ropivacaine;
  • Infection at block site or severe systemic infection;
  • Refuse to attend the trial.

Outcomes

Primary Outcomes

KPS score

Time Frame: 7 days post-surgery

Karnofsky performance score (KPS) allows patients to be classified as to their functional impairment. The total scale range is 0-100. The lower the KPS score, the worse the survival for most serious illnesses.

Secondary Outcomes

  • serum TNF-α levels(at 1h and 24h post-surgery)
  • Hospitalization Days(up to 30 days)
  • out of pocket expenditure for hospitalisation(hospital discharge/up to 30 days)
  • pain-relief medications(at 1, 2 and 3 days post-surgery)
  • KPS score(3 days post-surgery)
  • white blood cell(at 24 h after surgery)
  • serum IL-1β levels(at 1h and 24h post-surgery)
  • serum levels of CRP(at 24 h after surgery)
  • VAS score(at 1, 2 and 3 days post-surgery)
  • serum IL-6 levels(at 1h and 24h post-surgery)
  • Iowa Satisfaction with Anesthesia Scale (ISAS)(1 hour after the surgery is finished)
  • complications(within 30 days after surgery)

Study Sites (1)

Loading locations...

Similar Trials